Sign In

Liver Transplantation is the official journal of AASLD. This journal contains the latest research findings, as well as other relevant scientific data.

Edited by: Dr. Paul Martin
View complete editorial board

Impact Factor: 3.752
ISI Journal Citation Reports© Ranking 2017: 8/25 (Transplantation); 22/200 (Surgery); 24/80 (Gastroenterology & Hepatology)

NEW! Monthly Twitter Chat

The next Liver Transplantation Journal Club Twitter chat is Tuesday, December 11 at 7 pm EST. The topic of discussion: "Piggy‐back or cava replacement – which implantation technique protects liver recipients from acute kidney injury and complications?"

Read the related article(s) prior to the chat and come prepared to discuss.

To participate, follow the Liver Transplantation journal on Twitter.

New Editorial Focus: An Interview with Dr. Paul Martin

Read the editorial [PDF] by editor-in-chief Paul Martin, MD, FAASLD to learn more.

By visiting Liver Transplantation one can find the latest research findings, relevant scientific data, and the Journals EarlyView (articles in advance of print). Readers may view the full-text articles in Liver Transplantation Online including an electronic back-file dating back to 1995.

Submit and Review Manuscripts 

To submit a manuscript directly online, please visit: http://mc.manuscriptcentral.com/aasld. This site provides complete instructions on how to prepare and submit your manuscript electronically.

Journal Access

Members – As an AASLD member subscriber to HEPATOLOGY and/or Liver Transplantation, a Wiley InterScience (WIS) account has been created for you to access the journal(s) online. If you have not received this login information, or you simply forgot it, you can retrieve this information here.

Non-Members -- Please visit our publisher John Wiley & Sons for more information.

Direct all comments about Liver Transplantation to Karey Martinez at livertransplantation@aasld.org.

From AASLD News

New Journal Club Takes Debate to Twitter Platform
The Liver Transplantation Journal Club kicks off on August 15 with a moderated Twitter discussion on the pros and cons of steroid weaning in transplant recipients with autoimmune hepatitis.

Read the article..